Evidence map›Paper›PMID 35936572›Full record

ArticleAnnals of medicine and surgery (2012)2022

Guillain-Barré Syndrome associated with SARS-CoV-2 infection in Nepal: A case report.

Shriya Sharma, Aakriti Adhikari, Nirmal Ghimire, Gaurab Mainali, Sumit Kumar Yadav, Ruja Rajkarnikar

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Shriya SharmaNepalese Army Institute of Health Sciences, Kathmandu, Nepal.
Aakriti AdhikariNepalese Army Institute of Health Sciences, Kathmandu, Nepal.
Nirmal GhimireDepartment of Internal Medicine, Nepal Police Hospital, Kathamandu, Nepal.
Gaurab MainaliNepalese Army Institute of Health Sciences, Kathmandu, Nepal.
Sumit Kumar YadavDepartment of Internal Medicine, Shree Birendra Hospital, Kathmandu, Nepal.
Ruja RajkarnikarKathmandu Medical College and Teaching Hospital, Kathmandu, Nepal.
Nepalese Army Institute of Health Services · NPBir Hospital · NPKathmandu Medical College Teaching Hospital · NPNepal Medical College Teaching Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Corona viruses may also affect the central nervous system, inducing various neurological problems. Guillain-Barré Syndrome (GBS) is a rare immune-mediated post-infectious neuropathy typically leading to ascending weakness. Herein, we present a case of the patient to show an association of GBS and SARS-CoV-2 infection in Nepal. Case presentation: Twenty-seven yrs old man show an association of GBS and SARS-CoV-2 infection in Nepal who presented with difficulty in walking, backache, tingling sensations over the bilateral wrist and ankle, and features of facial nerve palsy. The diagnosis of GBS was made. Following Intravenous Immunoglobulin (IVIg) administration, the patient started showing motor recovery within a week. Clinical discussion: Patient who developed GBS as a likely post-infectious complication after the initial onset of infectious symptoms with persistent mild dry cough. Conclusion: GBS has severe complications and early diagnosis is important to monitor for loss of ambulation and initiation of immunoglobulin treatment. GBS should be considered as a potential rare but serious complication due to COVID-19.

Indexed as

COVID-19Guillain-Barré syndromeIntravenous immunoglobulinNepal

Identifiers

PMID35936572
PMCPMC9339100
OpenAlexW4288926716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.